Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
Loriot, Y., Bianchini, D., Ileana, E., Sandhu, S., Patrikidou, A., Pezaro, C., Albiges, L., Attard, G., Fizazi, K., De Bono, J.S., Massard, C.
Published in Annals of oncology (01.07.2013)
Published in Annals of oncology (01.07.2013)
Get full text
Journal Article
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
Bianchini, D, Lorente, D, Rodriguez-Vida, A, Omlin, A, Pezaro, C, Ferraldeschi, R, Zivi, A, Attard, G, Chowdhury, S, de Bono, J.S
Published in European journal of cancer (1990) (01.01.2014)
Published in European journal of cancer (1990) (01.01.2014)
Get full text
Journal Article
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
Tolcher, A.W., Quinn, D.I., Ferrari, A., Ahmann, F., Giaccone, G., Drake, T., Keating, A., de Bono, J.S.
Published in Annals of oncology (01.04.2012)
Published in Annals of oncology (01.04.2012)
Get full text
Journal Article
Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
Fizazi, K, De Bono, J.S, Flechon, A, Heidenreich, A, Voog, E, Davis, N.B, Qi, Ming, Bandekar, R, Vermeulen, J.T, Cornfeld, M, Hudes, G.R
Published in European journal of cancer (1990) (01.01.2012)
Published in European journal of cancer (1990) (01.01.2012)
Get full text
Journal Article
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
Molife, L. R., Attard, G., Fong, P. C., Karavasilis, V., Reid, A. H. M., Patterson, S., Riggs, C. E., Higano, C., Stadler, W. M., McCulloch, W., Dearnaley, D., Parker, C., de Bono, J. S.
Published in Annals of oncology (01.01.2010)
Published in Annals of oncology (01.01.2010)
Get full text
Journal Article
AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines
Puglisi, M, Thavasu, P, Stewart, A, de Bono, J.S, O’Brien, M.E.R, Popat, S, Bhosle, J, Banerji, U
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2014)
Get full text
Journal Article
Patient-Level DNA Damage and Repair Pathway Profiles Are Prognostic After Prostatectomy for High-Risk Prostate Cancer
Evans, J.R, Zhao, S.G, Tomlins, S.A, Knudsen, K.E, de Bono, J.S, Rubin, M.A, Klein, E.A, Den, R.B, Dicker, A.P, Karnes, J.R, Davicioni, E, Feng, F.Y
Published in International journal of radiation oncology, biology, physics (01.11.2015)
Published in International journal of radiation oncology, biology, physics (01.11.2015)
Get full text
Journal Article
2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC)
Lorente, D, Ravi, P, Mehra, N, Gillman, A, Omlin, A, Pezaro, C, Miranda, M, Mateo, J, Rescigno, P, Kolinsky, M, Porta, N, Jayaram, A, Bianchini, D, Hall, E, Ijzerman, M.J, De Bono, J.S
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Progressive computed tomography (CT) appearances preceding malignant spinal cord compression (MSCC) in men with castration-resistant prostate cancer
Pezaro, C, Omlin, A, Perez-Lopez, R, Mukherji, D, Attard, G, Bianchini, D, Lorente, D, Parker, C, Dearnaley, D, de Bono, J.S, Sohaib, A, Tunariu, N
Published in Clinical radiology (01.04.2015)
Published in Clinical radiology (01.04.2015)
Get full text
Journal Article
Impact of Node Status and Radiotherapy on Failure-Free Survival in Patients With Newly–Diagnosed Non-Metastatic Prostate Cancer: Data From >690 Patients in the Control Arm of the STAMPEDE Trial
James, N.D, Spears, M.R, Clarke, N.W, Sydes, M.R, Parker, C.C, Dearnaley, D.P, Russell, J.M, Ritchie, A.W.S, Thalmann, G, De Bono, J.S, Attard, G, Amos, C, Parmar, M.K, Mason, M.D
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Get full text
Journal Article
Pembrolizumab (pembro) for docetaxel-pretreated metastatic Castration-Resistant Prostate Cancer (mCRPC): Update on KEYNOTE-199, cohorts 1-3
Piulats, J.M., Antonarakis, E.S., Gross-Goupil, M., Goh, J.C., Vaishampayan, U.N., De Wit, R., Alanko, T., Fukasawa, S., Tabata, K., Feyerabend, S., Berger, R., Wu, H., Kim, J., Schloss, C., De Bono, J.S.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus enzalutamide (enza) for enza-resistant metastatic castration-resistant prostate cancer (mCRPC)
McDermott, R., Graff, J.N., Antonarakis, E.S., Hoimes, C.J., Tagawa, S.T., Hwang, C., Kilari, D., Tije, A.J.T., Omlin, A., Vaishampayan, U.N., Elliott, A., Wu, H., Kim, J., Schloss, C., De Bono, J.S.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
223 POSTER Pharmacokinetics and pharmacodynamic biomarkers for the pan-PI3K inhibitor GDC-0941: Initial Phase I evaluation
LoRusso, P, Sarker, D, Von Hoff, D, Tibes, R, Derynck, M.K, Ware, J.A, Yan, Y, Demetri, G.D, de Bono, J.S, Wagner, A.J
Published in European journal of cancer supplements (01.10.2008)
Published in European journal of cancer supplements (01.10.2008)
Get full text
Journal Article
352 Final Results of the First in Man Trial of MK4827, a Poly (ADP-ribose) Polymerase (PARP) Inhibitor with Antitumor Activity in BRCA Carriers and Sporadic Cancer Patients
Sandhu, S.K, Wilding, G, Schelman, W.R, Omlin, A, Kreischer, N, Carpenter, C, Iannone, R, Kaye, S, de-Bono, J.S, Wenham, R.M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
Prostate Radiotherapy for Men with Metastatic Disease: A New Comparison in the STAMPEDE Trial
Parker, C.C, Sydes, M.R, Mason, M.D, Clarke, N.W, Aebersold, D, de Bono, J.S, Dearnaley, D.P, Ritchie, A.W.S, Russell, J.M, Thalmann, G, Parmar, M.K.B, James, N.D
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.05.2013)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.05.2013)
Get full text
Journal Article
31 Evaluating the antitumour activity of docetaxel following treatment with abiraterone acetate and steroids: Evidence for cross-resistance
Mezynski, J, Attard, G, Zivi, A, Bianchini, D, Sandhu, S, Cassidy, A. Mulick, Thompson, E, Reid, A, Baikady, B, de Bono, J.S
Published in Critical reviews in oncology/hematology (2011)
Published in Critical reviews in oncology/hematology (2011)
Get full text
Journal Article
7000 ORAL Final Overall Survival (OS) Analysis of COU-AA-301, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pretreated With Docetaxel
Fizazi, K, Scher, H.I, Molina, A, Logothetis, C.J, Jones, R.J, Staffurth, J.N, Li, J, Kheoh, T, Haqq, C.M, de Bono, J.S
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article